Literature DB >> 18083961

Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients.

J J Sandra Kooij1, A Marije Boonstra, S H N Swinkels, Evelijne M Bekker, Ineke de Noord, Jan K Buitelaar.   

Abstract

OBJECTIVE: To study the correlation between symptoms of ADHD in adults, obtained with different methods and from different sources.
METHOD: Information was obtained from 120 adults with ADHD, their partners, and their parents, using the ADHD Rating Scale, the Conners' Adult ADHD Rating Scales (CAARS), the Brown Attention-Deficit Disorder Scale (BADDS), and the structured interview Diagnostic Interview Schedule-IV, section L (DIS-L).
RESULTS: All self-report rating scales can be used to assess ADHD symptoms in clinical samples of adults. The BADDS and the ADHD Rating Scale proved best in predicting the clinical diagnosis. The DSM-IV factors, originally developed for children, achieve lower patient-informant agreement than the other factors.
CONCLUSION: Adults with ADHD appear to be the best informants with regard to their symptoms but tend to underreport the severity of their symptoms. Informant report may be used to get additional information on symptoms and impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18083961     DOI: 10.1177/1087054707299367

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  85 in total

Review 1.  Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.

Authors:  Timothy E Wilens; Thomas J Spencer
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

2.  A network analysis of developmental change in ADHD symptom structure from preschool to adulthood.

Authors:  Michelle M Martel; Cheri A Levinson; Julia K Langer; Joel T Nigg
Journal:  Clin Psychol Sci       Date:  2016-03-04

3.  Effects of acupuncture versus cognitive behavioral therapy on cognitive function in cancer survivors with insomnia: A secondary analysis of a randomized clinical trial.

Authors:  Kevin T Liou; James C Root; Sheila N Garland; Jamie Green; Yuelin Li; Q Susan Li; Philip W Kantoff; Tim A Ahles; Jun J Mao
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

4.  Borderline personality traits and adult attention-deficit hyperactivity disorder symptoms: a genetic analysis of comorbidity.

Authors:  Marijn A Distel; Angela Carlier; Christel M Middeldorp; Catherine A Derom; Gitta H Lubke; Dorret I Boomsma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-02       Impact factor: 3.568

Review 5.  ADD/ADHD and Impaired Executive Function in Clinical Practice.

Authors:  Thomas E Brown
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

6.  Testing the dual pathway model of ADHD in obesity: a pilot study.

Authors:  Saskia Van der Oord; Caroline Braet; Samuele Cortese; Laurence Claes
Journal:  Eat Weight Disord       Date:  2017-03-07       Impact factor: 4.652

7.  Symptom dimensions of attention deficit hyperactivity disorder and nicotine withdrawal symptoms.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  J Addict Dis       Date:  2012

8.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.

Authors:  Arnt F A Schellekens; K P Grootens; C Neef; Kris L L Movig; J K Buitelaar; B Ellenbroek; R J Verkes
Journal:  Psychopharmacology (Berl)       Date:  2009-10-16       Impact factor: 4.530

9.  Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults.

Authors:  Dorret I Boomsma; Viatcheslav Saviouk; Jouke-Jan Hottenga; Marijn A Distel; Marleen H M de Moor; Jacqueline M Vink; Lot M Geels; Jenny H D A van Beek; Meike Bartels; Eco J C de Geus; Gonneke Willemsen
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

Review 10.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.